NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

光學成像技術市場

Optical Imaging Techniques

出版商 Global Industry Analysts, Inc. 商品編碼 939299
出版日期 內容資訊 英文 544 Pages
商品交期: 最快1-2個工作天內
價格
光學成像技術市場 Optical Imaging Techniques
出版日期: 2021年05月01日內容資訊: 英文 544 Pages
簡介

全球光學成像技術市場到2025年預計將達到25億美元。市場成長的主要因素有疾病預防,早期發現,診斷,治療上醫療影像的重要性。

本報告提供全球光學成像技術市場的相關調查,提供市場佔有率,趨勢和成長要素,新型冠狀病毒感染疾病的影響,各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

簡介,調查手法,調查範圍

摘要整理

第1章 市場概要

  • 新型冠狀病毒感染疾病的影響,全球景氣衰退
  • 簡介
  • 目前市場方案與展望
  • 先進地區:技術主要的消費者
  • 各地區的全球市場:已開發國家與新興地區的收益明細
  • 推動未來成長的新興地區
  • 未來的成長的市場排行榜(年複合成長率):中國,亞太地區、 南美,中東·非洲,加拿大,美國,歐洲,日本
  • 推動新興地區對醫學影像服務需求的關鍵因素
  • 對醫療保健的認識提高
  • 許多醫院和診所增加了獲得醫療保健的機會並增加了急診室
  • 醫療旅遊快速增長
  • 光學相干斷層掃描:主要的光學成像技術
  • 高光譜成像的機會
  • 走向近紅外光譜
  • 光聲層析成像技術的進展
  • 全球競爭市場份額
  • 全球競爭性市場份額情況

第2章 主要企業

  • Abbott Laboratories (美國)
  • Agfa-Gevaert Group (比利時)
  • ASE Optics Europe (西班牙)
  • Canon U.S.A., Inc. (美國)
  • Carl-Zeiss Meditec AG (德國)
  • ChemImage Corporation (美國)
  • Cytoviva Inc. (美國)
  • Headwall Photonics, Inc. (美國)
  • Heidelberg Engineering GmbH (德國)
  • Koninklijke Philips N.V. (荷蘭)
  • Leica Microsystems GmbH (德國)
  • Optical Imaging Ltd. (以色列)
  • PerkinElmer, Inc. (美國)
  • Topcon Corporation (Japan) (日本)

第3章 市場趨勢及成長要素

第4章 全球市場預測

市場分析

  • 各地區市場分析
  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 其他地區

競爭

  • 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP13750

Abstract:

Global Optical Imaging Techniques Market to Reach US$3.6 Billion by the Year 2027

Amid the COVID-19 crisis, the global market for Optical Imaging Techniques estimated at US$1.7 Billion in the year 2020, is projected to reach a revised size of US$3.6 Billion by 2027, growing at a CAGR of 11.4% over the analysis period 2020-2027.Optical Coherence Tomography, one of the segments analyzed in the report, is projected to grow at a 12.9% CAGR to reach US$1.7 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Hyperspectral Imaging segment is readjusted to a revised 10.3% CAGR for the next 7-year period. This segment currently accounts for a 26.5% share of the global Optical Imaging Techniques market.

The U.S. Accounts for Over 29.5% of Global Market Size in 2020, While China is Forecast to Grow at a 10.9% CAGR for the Period of 2020-2027

The Optical Imaging Techniques market in the U.S. is estimated at US$504.2 Million in the year 2020. The country currently accounts for a 29.52% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$634.4 Million in the year 2027 trailing a CAGR of 10.9% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.2% and 9.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.2% CAGR while Rest of European market (as defined in the study) will reach US$634.4 Million by the year 2027.

Near-infrared Spectroscopy Segment Corners a 19.7% Share in 2020

In the global Near-infrared Spectroscopy segment, USA, Canada, Japan, China and Europe will drive the 9.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$269.8 Million in the year 2020 will reach a projected size of US$506.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$426.4 Million by the year 2027.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • Agfa-Gevaert Group
  • ASE Optics Europe
  • Canon U.S.A., Inc.
  • Carl-Zeiss Meditec AG
  • ChemImage Corporation
  • Cytoviva Inc.
  • Headwall Photonics, Inc.
  • Heidelberg Engineering GmbH
  • Koninklijke Philips N.V.
  • Leica Microsystems GmbH
  • Optical Imaging Ltd.
  • PerkinElmer, Inc.
  • Topcon Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • An Introduction to Optical Imaging
    • Optical Imaging: Current Market Scenario and Outlook
    • Developed Regions: Dominant Consumers of Optical Imaging Technologies
    • EXHIBIT 1: World Optical Imaging Market by Region: Percentage Breakdown of Revenues for Developed and Developing Regions (2019 & 2025)
    • Developing Regions to Spearhead Future Growth
    • EXHIBIT 2: World Optical Imaging Market - Geographic Regions Ranked by CAGR (Value) for 2018-2025: China, Asia-Pacific, Latin America, Middle East, Africa, Canada, USA, Europe, and Japan
    • Key Factors Driving Demand for Medical Imaging Services in Developing Regions
    • Growing Healthcare Awareness
    • Increased Access to Healthcare and Surge in Number of Hospitals & Clinics
    • Proliferation of Medical Tourism
    • Optical Coherence Tomography: Major Optical Imaging Technique
    • Robust Opportunities for Hyperspectral Imaging
    • Near-infrared Spectroscopy Gains Traction
    • Photoacoustic Tomography Set to Make Gains
  • 2. FOCUS ON SELECT PLAYERS
    • Abbott Laboratories (USA)
    • Agfa-Gevaert Group (Belgium)
    • ASE Optics Europe (Spain)
    • Canon U.S.A., Inc. (USA)
    • Carl-Zeiss Meditec AG (Germany)
    • ChemImage Corporation (USA)
    • Cytoviva Inc. (USA)
    • Headwall Photonics, Inc. (USA)
    • Heidelberg Engineering GmbH (Germany)
    • Koninklijke Philips N.V. (Netherlands)
    • Leica Microsystems GmbH (Germany)
    • Optical Imaging Ltd. (Israel)
    • PerkinElmer, Inc. (USA)
    • Topcon Corporation (Japan)
  • 3. MARKET TRENDS & DRIVERS
    • Hospitals & Clinics: Dominant Consumers of Optical Imaging Solutions
    • Optical Imaging Remains Highly Relevant in Research Laboratories
    • Rising Prominence of Optical Imaging Technologies for Pharmaceutical & Biotech Firms
    • Growing Investments in Healthcare & Lifescience Sectors Create Conducive Environment for Growth of Optical Imaging Market
    • EXHIBIT 3: World Healthcare Spending & Growth (in US$ Trillion) and % Real GDP Growth for the Years 2012 through 2018
    • High Growth Opportunities in Oncology Care
    • EXHIBIT 4: Worldwide Incidence of Cancer (2012, 2018 & 2040): Number of New Cases Diagnosed
    • Growing Adoption in Cardiology Applications Bodes Well
    • Demographic Factors Favor Growth
    • Market Stands to Gain from Expanding Geriatric Population
    • EXHIBIT 5: Global Aging Population (in Thousands) by Age Group: 1975-2050
    • EXHIBIT 6: Elderly Population (60+ Years) as a Percentage of Total Population (2015 & 2050)
    • EXHIBIT 7: Life Expectancy at Birth in Years of People in Select Countries (2017)
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Optical Imaging Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Optical Imaging Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Optical Imaging Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Optical Coherence Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Optical Coherence Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Optical Coherence Tomography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Hyperspectral Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Hyperspectral Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Hyperspectral Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Near-infrared Spectroscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Near-infrared Spectroscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Near-infrared Spectroscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Photoacoustic Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Photoacoustic Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Photoacoustic Tomography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Ophthalmology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 28: World Current & Future Analysis for Other Therapeutic Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 29: World Historic Review for Other Therapeutic Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: World 15-Year Perspective for Other Therapeutic Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 31: World Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 32: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 34: World Current & Future Analysis for Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 35: World Historic Review for Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: World 15-Year Perspective for Research Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 37: World Current & Future Analysis for Pharma & Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 38: World Historic Review for Pharma & Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: World 15-Year Perspective for Pharma & Biotech by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 40: USA Current & Future Analysis for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: USA Historic Review for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: USA 15-Year Perspective for Optical Imaging Techniques by Technique - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography for the Years 2012, 2020 & 2027
    • TABLE 43: USA Current & Future Analysis for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: USA Historic Review for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: USA 15-Year Perspective for Optical Imaging Techniques by Therapeutic Type - Percentage Breakdown of Value Sales for Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types for the Years 2012, 2020 & 2027
    • TABLE 46: USA Current & Future Analysis for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: USA Historic Review for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: USA 15-Year Perspective for Optical Imaging Techniques by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Research Laboratories and Pharma & Biotech for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 49: Canada Current & Future Analysis for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Canada Historic Review for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: Canada 15-Year Perspective for Optical Imaging Techniques by Technique - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography for the Years 2012, 2020 & 2027
    • TABLE 52: Canada Current & Future Analysis for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Canada Historic Review for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: Canada 15-Year Perspective for Optical Imaging Techniques by Therapeutic Type - Percentage Breakdown of Value Sales for Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types for the Years 2012, 2020 & 2027
    • TABLE 55: Canada Current & Future Analysis for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Canada Historic Review for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: Canada 15-Year Perspective for Optical Imaging Techniques by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Research Laboratories and Pharma & Biotech for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 58: Japan Current & Future Analysis for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: Japan Historic Review for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: Japan 15-Year Perspective for Optical Imaging Techniques by Technique - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography for the Years 2012, 2020 & 2027
    • TABLE 61: Japan Current & Future Analysis for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Japan Historic Review for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: Japan 15-Year Perspective for Optical Imaging Techniques by Therapeutic Type - Percentage Breakdown of Value Sales for Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types for the Years 2012, 2020 & 2027
    • TABLE 64: Japan Current & Future Analysis for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Japan Historic Review for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: Japan 15-Year Perspective for Optical Imaging Techniques by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Research Laboratories and Pharma & Biotech for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 67: China Current & Future Analysis for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: China Historic Review for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: China 15-Year Perspective for Optical Imaging Techniques by Technique - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography for the Years 2012, 2020 & 2027
    • TABLE 70: China Current & Future Analysis for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: China Historic Review for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: China 15-Year Perspective for Optical Imaging Techniques by Therapeutic Type - Percentage Breakdown of Value Sales for Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types for the Years 2012, 2020 & 2027
    • TABLE 73: China Current & Future Analysis for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: China Historic Review for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: China 15-Year Perspective for Optical Imaging Techniques by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Research Laboratories and Pharma & Biotech for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 76: Europe Current & Future Analysis for Optical Imaging Techniques by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 77: Europe Historic Review for Optical Imaging Techniques by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: Europe 15-Year Perspective for Optical Imaging Techniques by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 79: Europe Current & Future Analysis for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: Europe Historic Review for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: Europe 15-Year Perspective for Optical Imaging Techniques by Technique - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography for the Years 2012, 2020 & 2027
    • TABLE 82: Europe Current & Future Analysis for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: Europe Historic Review for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: Europe 15-Year Perspective for Optical Imaging Techniques by Therapeutic Type - Percentage Breakdown of Value Sales for Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types for the Years 2012, 2020 & 2027
    • TABLE 85: Europe Current & Future Analysis for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Europe Historic Review for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: Europe 15-Year Perspective for Optical Imaging Techniques by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Research Laboratories and Pharma & Biotech for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 88: France Current & Future Analysis for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: France Historic Review for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: France 15-Year Perspective for Optical Imaging Techniques by Technique - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography for the Years 2012, 2020 & 2027
    • TABLE 91: France Current & Future Analysis for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: France Historic Review for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: France 15-Year Perspective for Optical Imaging Techniques by Therapeutic Type - Percentage Breakdown of Value Sales for Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types for the Years 2012, 2020 & 2027
    • TABLE 94: France Current & Future Analysis for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: France Historic Review for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: France 15-Year Perspective for Optical Imaging Techniques by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Research Laboratories and Pharma & Biotech for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 97: Germany Current & Future Analysis for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Germany Historic Review for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: Germany 15-Year Perspective for Optical Imaging Techniques by Technique - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography for the Years 2012, 2020 & 2027
    • TABLE 100: Germany Current & Future Analysis for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Germany Historic Review for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 102: Germany 15-Year Perspective for Optical Imaging Techniques by Therapeutic Type - Percentage Breakdown of Value Sales for Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types for the Years 2012, 2020 & 2027
    • TABLE 103: Germany Current & Future Analysis for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Germany Historic Review for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 105: Germany 15-Year Perspective for Optical Imaging Techniques by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Research Laboratories and Pharma & Biotech for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 106: Italy Current & Future Analysis for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 107: Italy Historic Review for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 108: Italy 15-Year Perspective for Optical Imaging Techniques by Technique - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography for the Years 2012, 2020 & 2027
    • TABLE 109: Italy Current & Future Analysis for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 110: Italy Historic Review for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 111: Italy 15-Year Perspective for Optical Imaging Techniques by Therapeutic Type - Percentage Breakdown of Value Sales for Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types for the Years 2012, 2020 & 2027
    • TABLE 112: Italy Current & Future Analysis for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 113: Italy Historic Review for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 114: Italy 15-Year Perspective for Optical Imaging Techniques by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Research Laboratories and Pharma & Biotech for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 115: UK Current & Future Analysis for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 116: UK Historic Review for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 117: UK 15-Year Perspective for Optical Imaging Techniques by Technique - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography for the Years 2012, 2020 & 2027
    • TABLE 118: UK Current & Future Analysis for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 119: UK Historic Review for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 120: UK 15-Year Perspective for Optical Imaging Techniques by Therapeutic Type - Percentage Breakdown of Value Sales for Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types for the Years 2012, 2020 & 2027
    • TABLE 121: UK Current & Future Analysis for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 122: UK Historic Review for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 123: UK 15-Year Perspective for Optical Imaging Techniques by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Research Laboratories and Pharma & Biotech for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 124: Rest of Europe Current & Future Analysis for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 125: Rest of Europe Historic Review for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 126: Rest of Europe 15-Year Perspective for Optical Imaging Techniques by Technique - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography for the Years 2012, 2020 & 2027
    • TABLE 127: Rest of Europe Current & Future Analysis for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Rest of Europe Historic Review for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 129: Rest of Europe 15-Year Perspective for Optical Imaging Techniques by Therapeutic Type - Percentage Breakdown of Value Sales for Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types for the Years 2012, 2020 & 2027
    • TABLE 130: Rest of Europe Current & Future Analysis for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Rest of Europe Historic Review for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 132: Rest of Europe 15-Year Perspective for Optical Imaging Techniques by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Research Laboratories and Pharma & Biotech for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 133: Asia-Pacific Current & Future Analysis for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Asia-Pacific Historic Review for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 135: Asia-Pacific 15-Year Perspective for Optical Imaging Techniques by Technique - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography for the Years 2012, 2020 & 2027
    • TABLE 136: Asia-Pacific Current & Future Analysis for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 137: Asia-Pacific Historic Review for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 138: Asia-Pacific 15-Year Perspective for Optical Imaging Techniques by Therapeutic Type - Percentage Breakdown of Value Sales for Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types for the Years 2012, 2020 & 2027
    • TABLE 139: Asia-Pacific Current & Future Analysis for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 140: Asia-Pacific Historic Review for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 141: Asia-Pacific 15-Year Perspective for Optical Imaging Techniques by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Research Laboratories and Pharma & Biotech for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 142: Rest of World Current & Future Analysis for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 143: Rest of World Historic Review for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 144: Rest of World 15-Year Perspective for Optical Imaging Techniques by Technique - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography for the Years 2012, 2020 & 2027
    • TABLE 145: Rest of World Current & Future Analysis for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 146: Rest of World Historic Review for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 147: Rest of World 15-Year Perspective for Optical Imaging Techniques by Therapeutic Type - Percentage Breakdown of Value Sales for Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types for the Years 2012, 2020 & 2027
    • TABLE 148: Rest of World Current & Future Analysis for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 149: Rest of World Historic Review for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 150: Rest of World 15-Year Perspective for Optical Imaging Techniques by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Research Laboratories and Pharma & Biotech for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 42